Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Trial in Progress: An Open-Label Expansion Trial Evaluating the Safety, PK/PD, and Clinical Activity of Emavusertib (CA-4948) + Ibrutinib in R/R Primary CNS Lymphoma

Christian Grommes, Grzegorz S. Nowakowski, Allison C. Rosenthal, Matthew A Lunning, Radhakrishnan Ramchandren, Lucia Regales, Meaghan Fowle, Maureen Lane, Catherine Wang, Antonio Omuro, Lori A. Leslie, Carole Soussain, Anna Paulina Dabrowska-Iwanicka, Andrés José María Ferreri, Han Tun

Blood (2023) 142 (Supplement 1): 3143.

https://doi.org/10.1182/blood-2023-190391

Published: 2023

Journal Articles

Highly Sensitive Interleukin Score for Intra-Ocular Lymphoma Diagnosis: Evidence from Analysis of 5-Year Real-Life of Use

Blood (2023) 142 (Supplement 1): 3002.

https://doi.org/10.1182/blood-2023-182192

Published: 2023

Journal Articles

BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1

Blood (2023) 141 (10): 1209–1220.

https://doi.org/10.1182/blood.2022016943

Published: 2023

Includes: Multimedia, Supplemental data

Journal Articles

Trial in Progress: A Phase 1b/2 Study of GB5121, a Brain-Penetrant, Potent, Highly Selective, and Irreversible BTK Inhibitor for Relapsed/Refractory Primary/Secondary CNS Lymphoma and Primary Vitreoretinal Lymphoma

Carole Soussain, Samar Issa, Katharine L Lewis, Christian Grommes, Judith Fox, Renee Ward, Caryn Peterson, Matt Cravets, Anita Mathias, Judith Sosa, Brian J Kirby, Zhaoqing Ding, Isharat Yusuf, Mark J Rose, Marcos W Steinberg, Han W. Tun

Blood (2022) 140 (Supplement 1): 12068–12069.

https://doi.org/10.1182/blood-2022-158599

Published: 2022

Journal Articles

Efficacy of CAR-T Cells in Primary Central Nervous System Lymphomas: The French Experience of the National LOC Network

Blood (2022) 140 (Supplement 1): 7540–7541.

https://doi.org/10.1182/blood-2022-167784

Published: 2022

Journal Articles

Impact on Tumour Treatment and Outcome of Sars-Cov-2 Infection in 91 Patients with Primary CNS Lymphoma: A Real-Life Study of the International PCNSL Collaborative Group

Blood (2022) 140 (Supplement 1): 3785–3787.

https://doi.org/10.1182/blood-2022-167915

Published: 2022

Journal Articles

Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients

Matthew R. Wilson, Toby A. Eyre, Amy A. Kirkwood, Nicole Wong Doo, Carole Soussain, Sylvain Choquet, Nicolás Martinez-Calle, Gavin Preston, Matthew Ahearne, Elisabeth Schorb, Marie-Pierre Moles-Moreau, Matthew Ku, Chiara Rusconi, Jahanzaib Khwaja, Mayur Narkhede, Katharine L. Lewis, Teresa Calimeri, Eric Durot, Loïc Renaud, Andreas Kiesbye Øvlisen, Graham McIlroy, Timothy J. Ebsworth, Johnathan Elliot, Anna Santarsieri, Laure Ricard, Nimish Shah, Qin Liu, Adam S. Zayac, Francesco Vassallo, Laure Lebras, Louise Roulin, Naelle Lombion, Kate Manos, Ruben Fernandez, Nada Hamad, Alberto Lopez-Garcia, Deirdre O'Mahony, Praveen Gounder, Nathalie Forgeard, Charlotte Lees, Kossi Agbetiafa, Tim Strüßmann, Thura Win Htut, Aline Clavert, Hamish Scott, Anna Guidetti, Brett R. Barlow, Emmanuelle Tchernonog, Jeffery Smith, Fiona Miall, Christopher P. Fox, Chan Y. Cheah, Tarec Christoffer El Galaly, Andrés J.M. Ferreri, Kate Cwynarski, Pamela McKay

Blood (2022) 139 (16): 2499–2511.

https://doi.org/10.1182/blood.2021014506

Published: 2022

Includes: Supplemental data

Journal Articles

CAR T-cell therapy in primary central nervous system lymphoma: the clinical experience of the French LOC network

Blood (2022) 139 (5): 792–796.

https://doi.org/10.1182/blood.2021012932

Published: 2022

Includes: Supplemental data

Journal Articles

Radiotherapy (WBRT) or Autologous Stem-Cell Transplantation (ASCT) for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Long-Term Results of the Intergroup Anocef-Goelams Randomized Phase II Precis Study

Blood (2021) 138 (Supplement 1): 658.

https://doi.org/10.1182/blood-2021-146389

Published: 2021

Journal Articles

Early Integration of High Dose Methotrexate to Frontline DLBCL Therapy Does Not Impact CNS Relapse Compared to End of Treatment Delivery: A Multicentre International Analysis of 1384 Patients

Matthew R Wilson, Toby A. Eyre, Amy A Kirkwood, Nicole Wong Doo, Carole Soussain, Sylvain Choquet, Nicolas Martinex-Calle, Gavin Preston, Matthew J Ahearne, Elisabeth Schorb, Marie-Pierre Moles-Moreau, Matthew Ku, Chiara Rusconi, Jahanzaib Khwaja, Mayur Narkhede, Katharine L Lewis, Teresa Calimeri, Eric Durot, Loic Renaud, Andreas Kiesbye Øvlisen, Graham McIlroy, Tim Ebsworth, Johnathon Elliot, Anna Santarsiere, Laure Ricard, Nimish Shah, Qin Liu, Adam Zayac, Francesco Vassallo, Laure Lebras, Louise Roulin, Naelle Lombion, Kate Manos, Ruben Fernandez, Nada Hamad, Alberto Lopez-Garcia, Deirdre O'Mahony, Praveen Gounder, Nathalie Forgeard, Charlotte Lees, Kossi Agbetiafa, Tim Strüßmann, Thura Win Htut, Aline Clavert, Hamish W Scott, Anna Guidetti, Brett R Barlow, Jeffrey Smith, Tarec Christoffer El-Galaly, Chan Yoon Cheah, Andres JM Ferreri, Fiona Miall, Christopher P Fox, Kate Cwynarski, Pamela McKay

Blood (2021) 138 (Supplement 1): 452.

https://doi.org/10.1182/blood-2021-144820

Published: 2021

Journal Articles

Primary vitreoretinal lymphoma: a diagnostic and management challenge

Carole Soussain, Denis Malaise, Nathalie Cassoux

Blood (2021) 138 (17): 1519–1534.

https://doi.org/10.1182/blood.2020008235

Published: 2021

Includes: Supplemental data

Journal Articles

First Results of the Acsé Pembrolizumab Phase II in the Primary CNS Lymphoma (PCNSL) Cohort

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-141773

Published: 2020

Journal Articles

Temozolomide is effective and well tolerated in patients with primary vitreoretinal lymphoma

Blood (2020) 135 (20): 1811–1815.

https://doi.org/10.1182/blood.2019003073

Published: 2020

Journal Articles

Primary Diffuse Large B-Cell CNS Lymphoma over 80 Years: An Analysis of 110 Patients from the French Oculo-Cerebral Lymphoma (LOC) Network

Blood (2018) 132 (Supplement 1): 4206.

https://doi.org/10.1182/blood-2018-99-117331

Published: 2018

Journal Articles

Primary CNS Lymphomas (PCNSL) Patient-Derived Xenograft (PDX) Models Capture the Biological and Molecular Characteristics of the Disease

Frederic Pouzoulet, PhD, Agusti Alentorn, MD, Mailys Daniau, PhD, Karima Mokhtari, MD, Magali Le Garff-Tavernier, Frederic Davi, MD PhD, Matthieu Peyre, MD, Franck Assayag, Ingeneer, Dalila Labiod, Ingeneer, Khe Hoang-xuan, MD PhD, Carole Soussain, MD PhD

Blood (2017) 130 (Supplement 1): 4104.

https://doi.org/10.1182/blood.V130.Suppl_1.4104.4104

Published: 2017

Journal Articles

Ibrutinib: A Risk Factor for Invasive Fungal Infections?

Blood (2017) 130 (Supplement 1): 4323.

https://doi.org/10.1182/blood.V130.Suppl_1.4323.4323

Published: 2017

Journal Articles

Keep an Eye on CXCL-13: A Promising Biomarker to Help IL-10 and IL-6 for the Diagnosis of Intraocular Lymphomas

Chloe Friedrich, Myrto Costopoulos, PharmD, Gregory Lazarian, PharmD, Choquet Sylvain, Martine Brissard, Caroline Houillier, MD, Nathalie Cassoux, MD PhD, Carole Soussain, MD PhD, Veronique Leblond, Helene Merle-Beral, MD PhD, Valerie Touitou, MD PhD, Magali Le Garff-Tavernier

Blood (2017) 130 (Supplement 1): 2841.

https://doi.org/10.1182/blood.V130.Suppl_1.2841.2841

Published: 2017

Journal Articles

Temozolomide in Relapse/Refractory Primary Vitreo-Retinal Lymphoma (R/R PVRL): A New Effective, Well-Tolerated and Cheap Reference. Result of a Study on Behalf of the LOC Network

Choquet Sylvain, Marine Baron, Anne Lavaud, Carole Soussain, MD PhD, Valerie Touitou, MD PhD, Christine Fardeau, Nathalie Cassoux, MD PhD, Magali Le Garff-Tavernier, Mirto Costopoulos, Caroline Houillier, MD, Karim Maloum, Véronique Leblond, Emmanuel Gyan, MDPhD, Pierre Soubeyran, MD PhD

Blood (2017) 130 (Supplement 1): 2845.

https://doi.org/10.1182/blood.V130.Suppl_1.2845.2845

Published: 2017

Journal Articles

Efficacy and Safety of Intensive Etoposide Aracytine Consolidation Following Rituximab Methotrexate Temozolomide Induction in Newly Diagnosed Primary Central Nervous System Lymphoma

Blood (2017) 130 (Supplement 1): 1573.

https://doi.org/10.1182/blood.V130.Suppl_1.1573.1573

Published: 2017

Journal Articles

Prognostic Value of Early 18F-FDG PET/CT Scanner Evaluation in Immunocompetent Primary CNS Lymphoma Patients

Blood (2017) 130 (Supplement 1): 4169.

https://doi.org/10.1182/blood.V130.Suppl_1.4169.4169

Published: 2017

NARROW

Trial in Progress: An Open-Label Expansion Trial Evaluating the Safety, PK/PD, and Clinical Activity of Emavusertib (CA-4948) + Ibrutinib in R/R Primary CNS Lymphoma

Highly Sensitive Interleukin Score for Intra-Ocular Lymphoma Diagnosis: Evidence from Analysis of 5-Year Real-Life of Use

BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1

Trial in Progress: A Phase 1b/2 Study of GB5121, a Brain-Penetrant, Potent, Highly Selective, and Irreversible BTK Inhibitor for Relapsed/Refractory Primary/Secondary CNS Lymphoma and Primary Vitreoretinal Lymphoma

Efficacy of CAR-T Cells in Primary Central Nervous System Lymphomas: The French Experience of the National LOC Network

Impact on Tumour Treatment and Outcome of Sars-Cov-2 Infection in 91 Patients with Primary CNS Lymphoma: A Real-Life Study of the International PCNSL Collaborative Group

Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients

CAR T-cell therapy in primary central nervous system lymphoma: the clinical experience of the French LOC network

Radiotherapy (WBRT) or Autologous Stem-Cell Transplantation (ASCT) for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Long-Term Results of the Intergroup Anocef-Goelams Randomized Phase II Precis Study

Early Integration of High Dose Methotrexate to Frontline DLBCL Therapy Does Not Impact CNS Relapse Compared to End of Treatment Delivery: A Multicentre International Analysis of 1384 Patients

Primary vitreoretinal lymphoma: a diagnostic and management challenge

First Results of the Acsé Pembrolizumab Phase II in the Primary CNS Lymphoma (PCNSL) Cohort

Temozolomide is effective and well tolerated in patients with primary vitreoretinal lymphoma

Primary Diffuse Large B-Cell CNS Lymphoma over 80 Years: An Analysis of 110 Patients from the French Oculo-Cerebral Lymphoma (LOC) Network

Primary CNS Lymphomas (PCNSL) Patient-Derived Xenograft (PDX) Models Capture the Biological and Molecular Characteristics of the Disease

Ibrutinib: A Risk Factor for Invasive Fungal Infections?

Keep an Eye on CXCL-13: A Promising Biomarker to Help IL-10 and IL-6 for the Diagnosis of Intraocular Lymphomas

Temozolomide in Relapse/Refractory Primary Vitreo-Retinal Lymphoma (R/R PVRL): A New Effective, Well-Tolerated and Cheap Reference. Result of a Study on Behalf of the LOC Network

Efficacy and Safety of Intensive Etoposide Aracytine Consolidation Following Rituximab Methotrexate Temozolomide Induction in Newly Diagnosed Primary Central Nervous System Lymphoma

Prognostic Value of Early 18F-FDG PET/CT Scanner Evaluation in Immunocompetent Primary CNS Lymphoma Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only